Maria Contel, Roberto Sanchez-Delgado, and Richard Magliozzo, professors from Brooklyn College who are working on pharmaceutical research, talk about the complexities of their work, and how to strike a balance among the human, technical, and financial resources available to them without compromising their findings.

Comments [4]
Read all my commentd earlier in light of this.
I lost my technician and my chairman to PANCREATIC CANCER.
As a chemistry student at Brooklyn College, it's gratifying to hear that the excellent chemistry department at this college are being highlighted and appreciated. These professors are teaching the scientists of the next generation. The students in their labs are devoted to their work. Having been in Dr. Contel's lab, I am certain too that their work rivals any at the Ivies. Thanks to the Leonard Lopate show for inviting these guests. I hope CUNY and Brooklyn in general get more positive attention.
What about the new programs being discussed to change the worldwide research/deve paradigm to focus on the number of people helped rather than the number of units sold? The WHO is discussing this.
How is their research linked to pharmaceutical companies that patent their discoveries and make the drugs impossible to be sold to the poorest countries that really needed it?
Do they directly benefit form Pharmaceutical companies financial support?
Leave a Comment
Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.